Skip to content
Medical Health Aged Care, Mental Health

Clinicians Welcome New Guidance on AI scribe use in Healthcare by AHPRA and RACGP

PatientNotes 2 mins read

26 August 2024 - Melbourne, Australia –  Thousands of healthcare practitioners welcome recent statements from the Australian Health Practitioner Regulation Agency (AHPRA) and The Royal Australian College of General Practitioners (RACGP) regarding the safe use of AI scribes in healthcare.

These statements provide much-needed clarity for health professionals looking to leverage AI technologies like PatientNotes, a clinical note-taking tool that uses AI to write clinical notes, to improve efficiency and quality of care.

Darren Ross, CEO of PatientNotes and a Musculoskeletal Physiotherapist with over 25 years of clinical experience, emphasises the importance of this guidance.

"This clarity from AHPRA and the RACGP is a game-changer for the healthcare industry. It provides a solid framework for practitioners to confidently embrace AI tools that can significantly enhance patient care and reduce administrative burdens," Ross said.

“For patients this guidance ensures that their care remains at the forefront of AI implementation in healthcare. It means that when they encounter AI-powered tools like PatientNotes in their healthcare journey, they can be confident that these technologies are being used responsibly, with their privacy protected and their best interests in mind.”

Key points from the guidance include:

  • AHPRA supports the safe use of AI in healthcare, recognising its potential to improve health outcomes and create a more person-centered health system.

  • RACGP acknowledges that AI has great potential in general practice, while emphasising the need for careful risk mitigation.

  • Both organisations stress that practitioners remain responsible for delivering safe, quality care when using AI tools.

  • Transparency with patients and obtaining informed consent are highlighted as important considerations.

Ross added, "The thousands of health practitioners currently using PatientNotes can feel safe and supported, both from a product and industry perspective. We've always prioritised practitioner accountability, patient privacy, and transparency in our design, which aligns perfectly with this new guidance."

PatientNotes incorporates key principles outlined in the guidance, including:

  • Maintaining practitioner accountability and oversight

  • Ensuring transparency with patients 

  • Prioritising data privacy and security

  • Obtaining informed consent

Drawing on his extensive experience managing multiple clinics and advising hundreds of clinic owners on practice management, Ross commented: "As a practitioner, I understand first-hand the benefits of fast and efficient finalisation of clinical notes and the role this plays in the happiness of healthcare professionals and their patients. PatientNotes was developed to address these exact challenges, and this new guidance further validates our approach."

"We encourage clinicians to review the full guidance from AHPRA and RACGP. PatientNotes remains committed to the responsible development and use of AI to support healthcare professionals in providing high-quality patient care," Ross said.


Key Facts:

AHPRA statement: https://www.ahpra.gov.au/Resources/Artificial-Intelligence-in-healthcare.aspx

RACGP statement: https://www.racgp.org.au/running-a-practice/technology/business-technology/artificial-intelligence-ai-scribes-fact-sheet


About us:

PatientNotes takes the hassle out of clinical documentation by automatically drafting clinical notes for healthcare professionals based on regular client conversations. Using speech recognition and generative artificial intelligence (AI), PatientNotes crafts user-friendly clinical notes that are easy to review and finalise. Importantly, PatientNotes enhances clinical decision making and contributes to quality improvement and clinical care optimisation.


Contact details:

Key contact:

Darren Ross, CEO PatientNotes

hello@patientnotes.app

For more information on how PatientNotes aligns with these guidelines, please visit https://www.patientnotes.app

Media

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Employment Relations, Mental Health
  • 15/01/2025
  • 00:01
atWork Australia

New year, new hope for Australian employment seekers

As the new year begins, many people look to turn the page on old challenges and look forward with renewed hope. For individuals managing mental health challenges, this time can be an opportunity to reset and seek a fresh start. Recent research revealed that more than two in five (42.9%) Australians aged 16–85 have experienced a mental health concern at some point in their lives1, highlighting the widespread impact of mental health challenges. For many, finding meaningful employment is a transformative step in their journey, offering more than just financial independence – it provides a renewed sense of purpose, stability…

  • Contains:
  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.